LOWER UTI IN PREGNANCY EMPIRIC TREATMENT TABLE |
Drug |
Dose |
Duration |
Notes |
1st choice options |
Nitrofurantoin Immediate Release Capsules
|
50 mg every 6 hours
|
7 days
|
Avoid after 36+0 weeks due to risk of neonatal haemolysis.
Immediate / Prolonged Release should be stated on the prescription1
|
OR |
Nitrofurantoin Prolonged Release Capsules |
100 mg every 12 hours |
7 days |
2nd choice option |
Cefalexin*
|
500 mg every 8 hours |
7 days
|
Cephalosporins should not be used in severe penicillin allergy.
|
Alternative (if resistance to the above agents is suspected or if adherence to the above treatment course would be particularly problematic) |
Fosfomycin
|
3 g
|
Single dose
|
Fosfomycin should only be used after a careful risk benefit assessment. Data in pregnancy is limited but to date has not indicated teratogenicity. Manufacturer advises that Fosfomycin should only be used during pregnancy if clearly necessary. Fosfomycin should ideally be taken at night, on an empty stomach, and empty bladder to maximise absorption and effectiveness. |
*Seek specialist/microbiologist advice in case of severe penicillin allergy in pregnant patients if nitrofurantoin is not an option.
1Two nitrofurantoin formulations are available: nitrofurantoin immediate release capsules (Macrodantin®) and nitrofurantoin prolonged release capsules (MacroBid®). For the treatment of infection the prolonged release capsules are dosed twice daily whilst the standard capsules are dosed four times daily. These products are not interchangeable
|